EXHIBIT AJOINT FILING AGREEMENTIn accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the undersigned agree to the joint filing on behalf ofeach of them of a statement on Schedule 13G (including amendments thereto) with respect to the Common Stock of Spring Bank Pharmaceuticals, Inc. andfurther agree that this agreement be included as an exhibit to such filing. Each party to the agreement expressly authorizes each other party to file on itsbehalf any and all amendments to such statement. Each party to this agreement agrees that this joint filing agreement may be signed in counterparts.In evidence whereof, the undersigned have caused this Agreement to be executed on their behalf this 7th day of April, 2020.UBS ONCOLOGY IMPACT FUND L.P.ONCOLOGY IMPACT FUND (CAYMAN) MANAGEMENT L.P.By: Oncology Impact Fund (Cayman) Management L.P,By: MPM Oncology Impact Management LP,its General Partnerits General PartnerBy: MPM Oncology Impact Management LP,By: MPM Oncology Impact Management GP LLC,its General Partnerits General PartnerBy: MPM Oncology Impact Management GP LLC,By: /s/ Ansbert Gadickeits General PartnerName: Ansbert GadickeTitle: Managing MemberBy: /s/ Ansbert GadickeName: Ansbert GadickeTitle: Managing MemberMPM ONCOLOGY IMPACT MANAGEMENT LPMPM ONCOLOGY IMPACT MANAGEMENT GP LLCBy: MPM Oncology Impact Management GP LLC,By: /s/ Ansbert Gadickeits General PartnerName: Ansbert GadickeTitle: Managing MemberBy: /s/ Ansbert GadickeName: Ansbert GadickeTitle: Managing Member